The Effects and Mechanisms of Brief Training in Mindfulness Meditation and Hypnosis for Pain Management, Relative to an Inert Control

Status: Recruiting
Location: See location...
Intervention Type: Behavioral, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The aim of this study is to determine the effects and mechanisms of 1 x 20-min training in mindfulness meditation and self-hypnosis relative to an inert control. Participants will be randomly assigned to condition. The dual primary outcomes will be pre- to post-training changes in current pain intensity and pain unpleasantness. The active treatments are hypothesized to produce greater reductions in pain outcomes than the control. It is also hypothesized that change in mindfulness will be a mediator specific to mindfulness meditation, while change in affect and decentering will be mediators of the hypnosis condition. Moderators of response will also be explored.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Must be 18 years of age;

• Experience chronic or recurrent pain;

• Have access to a computer, phone or tablet with internet capability; and

• Be able to read and understand English.

Locations
Other Locations
Australia
The University of Queensland
RECRUITING
Brisbane
Contact Information
Primary
Melissa Day, Ph.D.
m.day@uq.edu.au
+61 7 3365 6421
Time Frame
Start Date: 2022-03-24
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 300
Treatments
Experimental: Mindfulness meditation
Participants in the mindfulness meditation condition will practice one, 20-minute breath and body focused meditation.
Active_comparator: Self-Hypnosis
Participants in self-hypnosis will practice one, 20-minute audio-guided hypnosis session with suggestions tailored towards enhancing positive affect and fostering decentering.
Other: Control
Participants in the attention control condition will listen to a 20-minute natural history recording.
Related Therapeutic Areas
Sponsors
Collaborators: University of Washington
Leads: The University of Queensland

This content was sourced from clinicaltrials.gov